Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Farrukh T. Awan · SciRah

Researcher profile · Semantic Scholar

Farrukh T. Awan

Share profile

Farrukh T. Awan — researcher profile on SciRah

h-index: 47
Works: 401
Citations: 8,709

Most-cited papers

Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
W. Kim, Tae Min Kim, Seok-Goo Cho, I. Jarque +126 more
2025Nature Cancer60 citations Open access
Semantic Scholar
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024.
W. Wierda, Jennifer R. Brown, J. S. Abramson, Farrukh T. Awan +32 more
2024The Journal of the National Comprehensive Cancer Network60 citations Open access
Semantic Scholar
ASTCT Clinical practice recommendations for transplant and cellular therapies in diffuse large B-cell lymphoma.
N. Epperla, Ambuj Kumar, S. Abutalib, Farrukh T. Awan +22 more
2023Transplantation and Cellular Therapy43 citations Open access
Semantic Scholar
Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1
Alexey V. Danilov, B. Fakhri, Farrukh T. Awan, H. Bentzen +19 more
2024Blood30 citations
Semantic Scholar
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma
R. Shouval, C. Strouse, Soyoung Kim, Temitope Oloyede +39 more
2025Transplantation and Cellular Therapy26 citations Open access
Semantic Scholar
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission
M. Shadman, K. W. Ahn, Manmeet Kaur, L. Lekakis +26 more
2024Blood Cancer Journal24 citations Open access
Semantic Scholar
CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma
P. Pophali, Josh Fein, Kwang Woo Ahn, Molly Allbee-Johnson +15 more
2024Blood Advances21 citations
Semantic Scholar
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study.
P. Strati, Januario E. Castro, Aaron Goodman, V. Bachanova +12 more
2025The Lancet Haematology19 citations
Semantic Scholar
Chimeric antigen receptor T‐cell therapy in secondary central nervous system lymphoma: A multicenter analysis
Aseel Alsouqi, Gulrayz Ahmed, Jun-Tian Wang, G. Cassanello +18 more
2024American journal of hematology/oncology18 citations
Semantic Scholar
Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis
M. Perales, Farrukh T. Awan, A. Boumendil, Jinalben Patel +24 more
2025Blood15 citations
Semantic Scholar
A Phase 1 Study of AC676, a Novel BTK Chimeric Degrader, in Patients with B-Cell Malignancies
M. Tees, D. Bond, Nadia Khan, Farrukh T. Awan +5 more
2024Blood14 citations
Semantic Scholar
CAR T-cell therapy in mantle cell lymphoma with secondary CNS involvement: a multicenter experience
Gulrayz Ahmed, Aseel Alsouqi, A. Szabo, Laura Samples +9 more
2024Blood Advances12 citations Open access
Semantic Scholar
EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL.
J. Vose, U. Vitolo, P. Lugtenburg, M. Chamuleau +15 more
2024Journal of Clinical Oncology9 citations Open access
Semantic Scholar
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
W. Wierda, Jennifer R. Brown, Jeremy S. Abramson, Farrukh T. Awan +33 more
2026The Journal of the National Comprehensive Cancer Network8 citations
Semantic Scholar
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma
U. Greenbaum, Hamza Hashmi, M. Elsawy, Soyoung Kim +41 more
2025Blood Advances8 citations
Semantic Scholar
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas
J. Soumerai, C. Diefenbach, D. Jagadeesh, A. Asch +12 more
2024British Journal of Haematology8 citations
Semantic Scholar
Interim Results from a Phase 2 Pivotal Study (DALY II USA) of Tandem CD20-CD19-Directed Non-Cryopreserved CAR-T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
N. Shah, R. Maziarz, C. Jacobson, Patrick B. Johnston +23 more
2024Blood8 citations
Semantic Scholar
Impact of Thiotepa Dose-Intensity in Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Undergoing Autologous Hematopoietic Cell Transplant with thiotepa/carmustine Conditioning
Shanze Arshad, Xi Fang, K. Ahn, Manmeet Kaur +5 more
2023Bone Marrow Transplantation6 citations Open access
Semantic Scholar
CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial
Daniel Nunez, J. Stadanlick, T. Furmanak, J. Goldenberg +29 more
2026Blood5 citations Open access
Semantic Scholar
Clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and chimeric antigen receptor T-cell therapy in patients with chronic lymphocytic leukemia on behalf of the American Society for Transplantation and Cellular Therapy.
M. Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, Jennifer R. Brown +17 more
2025Transplantation and Cellular Therapy5 citations Open access
Semantic Scholar
RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies
Prasad Koduru, Wei-Na Chen, Franklin S. Fuda, G. Kaur +4 more
2024Clinical Pathology5 citations Open access
Semantic Scholar
Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers
K. Annunzio, E. McLaughlin, T. Voorhees, L. Shea +25 more
2023Blood5 citations Open access
Semantic Scholar
Treatment Intensity and Outcomes in Elderly Patients with DLBCL Receiving First Line Therapy
S. Bair, M. Narkhede, Z. Frosch, E. Chong +6 more
2023Blood5 citations Open access
Semantic Scholar
Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Secondary Central Nervous System Large B-Cell Lymphoma (SCNSL): A Multicenter Retrospective Analysis
Gulrayz Ahmed, Aseel Alsouqi, A. Szabo, A. Rojek +16 more
2023Blood5 citations Open access
Semantic Scholar
IBCL-147 AC676, an Orally Bioavailable BTK Chimeric Degrader in Patients With B-cell Malignancies
Manish Patel, Michael Tees, Nadia Khan, Farrukh T. Awan +5 more
2024Clinical Lymphoma, Myeloma & Leukemia4 citations
Semantic Scholar
Abstract PO-009: AC676 a BTK Chimeric Degrader: Phase 1 study in patients with B-cell Malignancies
M. Patel, M. Tees, Farrukh T. Awan, N. Khan +4 more
2024Blood Cancer Discovery4 citations
Semantic Scholar
Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on Survival
R. Shouval, C. Strouse, Soyoung Kim, Temitope Oloyede +37 more
2023Blood4 citations Open access
Semantic Scholar
Adaptive Radiation Therapy in Lymphomas: Indications, Early Experiences, and Future Directions.
Kiran A. Kumar, Xinran Zhong, Zohaib Iqbal, P. Geethakumari +12 more
2025International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors
Mary Ann Anderson, A. Sverdlov, Farrukh T. Awan, L. Berkahn +6 more
2025Internal medicine journal (Print)3 citations Open access
Semantic Scholar
Pre-Lymphodepletion Endothelial Activation and Stress Index As a Predictor of Clinical Outcomes in B-Cell Maturation Antigen CAR T Therapy for Multiple Myeloma
Jimmy Lee, Harsh Vardhan Upreti, Aishwarya Sannareddy, H. Reves +17 more
2024Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Mutations in the Bruton Tyrosine Kinase (BTK) Gene in Patients with Chronic Lymphocytic Leukemia (CLL) Receiving BTK Inhibitors (BTKis)
A. Skarbnik, Alexey V. Danilov, Marc S. Hoffmann, Farrukh T. Awan +10 more
2024Blood3 citations
Semantic Scholar
A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study of CLN-978 (CD19XCD3XHSA) in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
G. Shouse, K. Blum, J. Haydu, J. Abramson +10 more
2023Blood3 citations Open access
Semantic Scholar
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma
Jospeh P. McGuirk, Armin Ghobadi, C. Bachier, P. Shaughnessy +24 more
2026Blood Advances2 citations Open access
Semantic Scholar
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
S. Ball, Farrukh T. Awan, Ben K. Tomlinson, Tess Stopczynski +8 more
2026American journal of hematology/oncology2 citations Open access
Semantic Scholar
Tandem CD20-CD19-Directed Non-Cryopreserved CAR T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Interim Results from a Phase 2 Pivotal Study (DALY II USA)
Nirav N. Shah, R. Maziarz, C. Jacobson, Patrick B. Johnston +24 more
2025Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas
Katherine Lake, M. Jackson, Samantha Hull, S. All +11 more
2025Frontiers in Oncology2 citations Open access
Semantic Scholar
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.
Sairah Ahmed, Ambuj Kumar, P. Carpenter, Alex F. Herrera +21 more
2025Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
W. Kim, Tae Min Kim, Seok-Goo Cho, I. Jarque +126 more
2025Nature Cancer2 citations Open access
Semantic Scholar
Assessing the Predictive Value of Pre-Lymphodepletion and Infusion Endothelial Activation and Stress Index in CD19-Directed CAR-T Therapy for B-Cell Lymphoma
Harsh Vardhan Upreti, Jimmy Lee, Aishwarya Sannareddy, H. Reves +17 more
2024Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
Phase I dose-escalation and cohort expansion study of the anti-BTLA antibody, tifcemalimab, in combination with toripalimab (anti-PD-1) in heavily pretreated patients (pts) with advanced malignancies.
Vincent T Ma, M. Milhem, M. Hidalgo, A. Shields +16 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Single-Agent Ibrutinib Versus Allogeneic Hematopoietic Cell Transplantation for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and del(17p)
Farrukh T. Awan, Ran Liu, Hsin-Hui Huang, Matthew Bye +5 more
2024Blood2 citations
Semantic Scholar
Abstract 17859: Real World Cardiovascular Events With Next Generation Bruton's Tyrosine Kinase Inhibitors - An Updated Analysis
Michael Poliner, Benjamin Buck, Sanam M. Ghazi, Sunnia T Chen +20 more
2023Circulation2 citations
Semantic Scholar
Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia
Richard R. Furman, W. Wierda, P. Patten, J. Chaves +14 more
2026Blood Advances1 citations Open access
Semantic Scholar
Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas
M. Munir, A. Sayed, Dae Hyun Lee, Farrukh T. Awan +4 more
2026Journal of Hematology & Oncology1 citations Open access
Semantic Scholar
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-cell Lymphoma Patients In remission after salvage treatments
F. Furqan, K. W. Ahn, Manmeet Kaur, Jinalben Patel +21 more
2025American journal of hematology/oncology1 citations Open access
Semantic Scholar
AML-117: A Phase 1b Study of Selinexor and Venetoclax in Patients With Relapsed or Refractory Acute Myeloid Leukemia
S. Ball, Michael T Byrne, Melissa A. Fischer, Farrukh T. Awan +13 more
2025Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Impact of insurance status on testicular cancer outcomes: A single-institution, dual-site study.
Ifeanyi Chidera Ibezue, Z. Khene, R. Bhanvadia, Y. Lotan +9 more
2025Urologic oncology1 citations
Semantic Scholar
Efficacy and safety of nemtabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: Cohort J of the phase 2 BELLWAVE-003 study.
T. Kipps, Farrukh T. Awan, B. Eichhorst, Y. Herishanu +11 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Incidence of Invasive Fungal Infections in CAR T-Cell Therapy Recipients: A Single Center Retrospective Analysis.
Aishwarya Sannareddy, Jimmy Lee, Harsh Vardhan Upreti, Laura Turer +23 more
2024Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
CLL-186 Interim Results From ASSURE: A Phase 3b Safety Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukemia
Stephen S. Opat, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin +19 more
2024Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Woyach×9
Invite
J. Woyach — researcher profile on SciRah
P. Riedell×8
Invite
P. Riedell — researcher profile on SciRah
M. Hamadani×7
Invite
M. Hamadani — researcher profile on SciRah
P. Geethakumari×6
Invite
P. Geethakumari — researcher profile on SciRah

Heather R Wolfe

×6

Invite

Heather R Wolfe — researcher profile on SciRah

M. Kharfan-Dabaja×5

Invite

M. Kharfan-Dabaja — researcher profile on SciRah

Sairah Ahmed×5

Invite

Sairah Ahmed — researcher profile on SciRah

A. Beitinjaneh×5

Invite

A. Beitinjaneh — researcher profile on SciRah

Invite

M. Iqbal — researcher profile on SciRah

Invite

M. Hamadani — researcher profile on SciRah

Invite

C. Sauter — researcher profile on SciRah

Invite

R. Shouval — researcher profile on SciRah